Trial · NCT00529568
Adverse events603
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 603
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pyrexia | General disorders | Eltrombopag: OL Phase | 0 | 805 | |
| other | Pyrexia | General disorders | Placebo+Antiviral Therapy: DB Phase | 60 | 252 | |
| other | Pyrexia | General disorders | Eltrombopag+Antiviral Therapy: DB Phase | 141 | 506 | |
| other | Fatigue | General disorders | Eltrombopag: OL Phase | 0 | 805 | |
| other | Fatigue | General disorders | Placebo+Antiviral Therapy: DB Phase | 53 | 252 | |
| other | Fatigue | General disorders | Eltrombopag+Antiviral Therapy: DB Phase | 124 | 506 | |
| other | Influenza like illness | General disorders | Eltrombopag: OL Phase | 0 | 805 | |
| other | Influenza like illness | General disorders | Placebo+Antiviral Therapy: DB Phase | 36 | 252 | |
| other | Influenza like illness | General disorders | Eltrombopag+Antiviral Therapy: DB Phase | 100 | 506 | |
| other | Asthenia | General disorders | Eltrombopag: OL Phase | 0 | 805 | |
| other | Asthenia | General disorders | Placebo+Antiviral Therapy: DB Phase | 28 | 252 | |
| other | Asthenia | General disorders | Eltrombopag+Antiviral Therapy: DB Phase | 86 | 506 | |
| other | Chills | General disorders | Eltrombopag: OL Phase | 0 | 805 | |
| other | Chills | General disorders | Placebo+Antiviral Therapy: DB Phase | 32 | 252 | |
| other | Chills | General disorders | Eltrombopag+Antiviral Therapy: DB Phase | 72 | 506 | |
| other | Irritability | General disorders | Eltrombopag: OL Phase | 0 | 805 | |
| other | Irritability | General disorders | Placebo+Antiviral Therapy: DB Phase | 11 | 252 | |
| other | Irritability | General disorders | Eltrombopag+Antiviral Therapy: DB Phase | 34 | 506 | |
| other | Edema peripheral | General disorders | Eltrombopag: OL Phase | 0 | 805 | |
| other | Edema peripheral | General disorders | Placebo+Antiviral Therapy: DB Phase | 3 | 252 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00529568/events